Appendix D
Table D.1 HIV Prevalence among STD Clinic Attendees, VCT Attendees, and People Suspected of Living with HIV Country
226
HIV prevalence among STD clinic attendees, VCT attendees, and people suspected of living with HIV
Algeria
2.0% (Institut de Formation Paramédicale de Parnet 2004) 1.24% (Unknown, “Statut de la réponse nationale”) 1.26% (Unknown, “Statut de la réponse nationale”) 0.25% (Alami 2009) 1.19% (Alami 2009) 2.4% (Alami 2009)
Djibouti
1.0% (Fox et al. 1989) 10.4% (Rodier et al. 1993)
Egypt, Arab Republic of
0.0% (Saleh et al. 2000) 0.23% (Watts et al. 1993) 8.4% (Ali et al. 1998)
Iran, Islamic Republic of
4.1% (Ghannad et al. 2009) 2.0% (Ghannad et al. 2009) 2.2% (Ghannad et al. 2009)
Kuwait
0.0% (Al-Owaish et al. 2000) 0.0% (Al-Fouzan and Al-Mutairi 2004) 0.0% (Al-Mutairi et al. 2007)
Morocco
0.15% (Khattabi and Alami 2005) 0.08% (Khattabi and Alami 2005) 0.25% (Khattabi and Alami 2005) 0.16% (Khattabi and Alami 2005) 0.1 (women; Ryan et al. 1998) 0.3% (women; Ryan et al. 1998) 2.9% (Ryan et al. 1998) 0.0% (men; WHO/EMRO Regional Database on HIV/AIDS) 0.2% (women; WHO/EMRO Regional Database on HIV/AIDS) 0.09% (Khattabi and Alami 2005) 0.23% (Khattabi and Alami 2005) 0.62% (Heikel et al. 1999) 5.0% (attendees with high risk and/or symptoms; Elmir et al. 2002) 0.10% (Khattabi and Alami 2005; Elharti et al. 2002) 0.25% (Elharti et al. 2002) 0.34% (Khattabi and Alami 2005) 0.26% (Khattabi and Alami 2005) 0.19% (Morocco MOH 2007)